Health officials launch clinical trial reforms to counter China threat

AI Summary

The FDA has initiated a pilot program to accelerate early-stage clinical trials aiming to shorten drug development timelines and counter the trend of companies relocating clinical research primarily to China. This move is part of a broader Department of Health and Human Services initiative.

The Food and Drug Administration (FDA) on Monday launched a new initiative to speed up early-stage clinical trials as part of an effort to reduce development timelines and reverse a growing trend of companies moving overseas, primarily to China.   The pilot program, part of a broader initiative across the Department of Health and Human…